| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.04 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |